Legato Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Legato Capital Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-19,963	Closed	-$767K	–	667
2023 Q2	$767K	Sell	19,963 -6,481	-25%	-$166K	0.1%	315
2023 Q1	$612K	Hold	26,444	–	–	0.11%	317
2022 Q4	$693K	Buy	+26,444	New	+$586K	0.13%	263

Legato Capital Management's KDNY Position: Q3 2023 in Review

Legato Capital Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 19,963 shares — an estimated $767K sold.

Legato Capital Management first reported a position in KDNY in Q4 2022 and held it in 3 quarters. The position peaked at $767K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Legato Capital Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Legato Capital Management sold 19,963 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $767K.
Legato Capital Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Legato Capital Management's Chinook Therapeutics, Inc. Common Stock position peaked at $767K in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Legato Capital Management's 13F filing for Q3 2023, filed 12 Oct 2023.